| Zacks Company Profile for Baxter International Inc. (BAX : NYSE) |
|
|
| |
| • Company Description |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Number of Employees: 38,000 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $31.23 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 3,363,781 shares |
| Shares Outstanding: 513.17 (millions) |
| Market Capitalization: $16,026.44 (millions) |
| Beta: 0.61 |
| 52 Week High: $40.49 |
| 52 Week Low: $26.25 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
3.79% |
-0.02% |
| 12 Week |
11.65% |
-10.24% |
| Year To Date |
7.10% |
1.63% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Brent Shafer - Chairman and Chief Executive Officer
Joel T. Grade - Executive Vice President; Chief Financial Officer
William A. Ampofo - Director
Jeffery A. Craig - Director
Patricia B. Morrison - Director
|
|
Peer Information
Baxter International Inc. (BJCT)
Baxter International Inc. (CADMQ)
Baxter International Inc. (APNO)
Baxter International Inc. (UPDC)
Baxter International Inc. (IMTIQ)
Baxter International Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 071813109
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/05/25
|
|
Share - Related Items
Shares Outstanding: 513.17
Most Recent Split Date: 5.00 (2.00:1)
Beta: 0.61
Market Capitalization: $16,026.44 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 2.18% |
| Current Fiscal Quarter EPS Consensus Estimate: $0.64 |
Indicated Annual Dividend: $0.68 |
| Current Fiscal Year EPS Consensus Estimate: $2.50 |
Payout Ratio: 0.26 |
| Number of Estimates in the Fiscal Year Consensus: 8.00 |
Change In Payout Ratio: -0.08 |
| Estmated Long-Term EPS Growth Rate: 13.59% |
Last Dividend Paid: 05/30/2025 - $0.17 |
| Next EPS Report Date: 08/05/25 |
|
|
|
| |
